SEC61G and head and neck squamous cell carcinoma: Interestingly, SEC61G expression was negatively correlated with PD‐L1 expression in HNSCC, and patients with high SEC61G expression seemed to have lower OS than did patients with low‐SEC61G expression in the dataset of metastatic urothelial cancer patients treated with atezolizumab.